Company: CNTB
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001835268-25-000014
Chunk: 12

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-03-31
Form: 10-K
Item: Item 11
Chunk 12
---
TABLE OF CONTENTS

ITEM 11.       EXECUTIVE COMPENSATION.

Summary Compensation Table

The table below sets forth certain compensation information for: (i) our current principal executive officer and any other individual who served in such capacity during our fiscal year ended December 31, 2024; (ii) our two most highly compensated executive officers other than our principal executive officer who were serving as executive officers at December 31, 2024; and (iii) up to two additional individuals for whom disclosure would have been required but for the fact that the individual was not serving as an executive officer at December 31, 2024 (together, our “Named Executive Officers”). Compensation information is shown for the years ended December 31, 2024 and 2023.

Name and Principal PositionYearSalary ($)OptionAwards ($) (1)Non-EquityIncentive PlanCompensation ($) (2)All OtherCompensation($)Total ($)Current Executive Officers:Barry D. Quart, Pharm.D. (3)2024$360,208 $3,973,970 $178,065 $9,193 $4,521,436 Chief Executive OfficerDavid Szekeres (4)2024$277,083 $2,739,770 $124,521 $7,701 $3,149,075 PresidentLisa Peraza, CPA (5)2024$156,061 $397,763 $50,135 $4,693 $608,652 Vice President, FinanceFormer Executive Officers:Zheng Wei, Ph.D. (6)2024$532,322 $294,657 $— $1,549,574 $2,376,553 Former Chief Executive Officer2023$505,000 $257,268 $218,295 $9,900 $990,463 Wubin Pan, Ph.D. (7)2024$512,000 $255,369 $— $1,315,961 $2,083,330 Former President2023$512,000 $222,966 $207,360 $— $942,326 Steven Chan (8)2024$307,333 $296,443 $— $466,056 $1,069,832 Former Chief Financial Officer2023$410,000 $115